Analysts’ Viewpoint on Market Scenario
Increase in prevalence of sleep disorders is expected to augment global polysomnography devices market progress during the forecast period. Polysomnography devices are used to monitor sleep stages and cycles. Advanced polysomnography devices possess the ability to wirelessly transmit data to healthcare providers for analysis.
Availability of portable and home-based devices is anticipated to fuel market development in the next few years. Compact and portable devices are gaining traction among the populace. Development of software with detailed and accurate analysis capabilities is likely to offer lucrative growth opportunities for market players. Key players are focusing on R&D of new devices to increase their polysomnography devices market share.
Polysomnography (PSG) devices are medical instruments used to monitor a person's sleep. These devices typically include Electroencephalogram (EEG) to measure brain activity, Electrooculogram (EOG) to record eye movement, and Electromyogram (EMG) to analyze muscle activity.
Polysomnography devices may also include other sensors to measure breathing, heart rate, and oxygen levels. The data collected by PSG devices is used to diagnose and evaluate sleep disorders such as insomnia, sleep apnea, and Rapid Eye Movement (REM) sleep behavior disorder.
Request a sample to get extensive insights into the Polysomnography Devices Market
Sleep disorders, such as insomnia, sleep apnea, and narcolepsy, can have an adverse impact on an individual's overall health and quality of life. Therefore, early diagnosis and treatment of these disorders is crucial. Polysomnography is a valuable tool for the diagnosis of sleep disorders.
According to the Centers for Disease Control and Prevention (CDC), sleep disorders are so persistent in the U.S. that they now constitute a public health epidemic. Almost 50 million people in the country reported problems concentrating during the day, 24 million indicated lack of sleep interfered with driving, and 18 million reported that sleep deficiency interfered with job performance. Thus, rise in cases of sleep disorders is estimated to spur polysomnography devices market growth in the near future.
R&D of advanced polysomnography devices and software has made polysomnography tests more accurate and efficient. New devices are more comfortable to wear for patients. Advanced software is designed to provide a more detailed and accurate analysis of the data collected during tests. This allows for more precise diagnosis and treatment of sleep disorders.
Companies are increasingly offering portable and home-based devices that are affordable. Thus, R&D of advanced polysomnography devices is likely to boost polysomnography devices market expansion in the next few years.
Request a custom report on Polysomnography Devices Market
The portable product segment dominated the polysomnography devices industry in 2021. Portable polysomnography devices are more convenient and less expensive than traditional in-lab testing.
These devices increase patient accessibility and compliance as well as provide more accurate test results than traditional in-lab testing.
According to the latest polysomnography devices market insights, the > 32 channel segment accounted for the largest share in 2021. > 32 channel PSG devices are often equipped with advanced features such as automatic scoring of sleep stages, software for data analysis, and the ability to store and transmit data digitally. These devices are used for complex sleep studies or the diagnosis of severe sleep disorders. > 32 channel PSG devices are also employed for research purposes.
The hospitals end-user segment dominated the polysomnography devices business in 2021. Polysomnography devices are widely used in hospitals compared to clinics and other healthcare settings.
According to the latest polysomnography devices market forecast, North America is expected to account for the largest share from 2022 to 2031. The region dominated the industry in 2021. High prevalence of sleep disorders is anticipated to boost market revenue in the region in the near future.
According to the CDC, the prevalence of short sleep duration in the U.S. was much higher in males than in females from 2013 to 2020. As per Canadian Health Measures Survey, 43% of men and 55% of women aged 18 years to 64 years have problems falling asleep.
Asia Pacific held the second-largest share in 2021. The market in the region is projected to grow at a rapid pace from 2022 to 2031. High prevalence of sleep disorders is likely to drive polysomnography devices market dynamics in Asia Pacific in the next few years.
According to the University of Warwick Medical School, 5%-6% of people aged 50 years and above may be affected by sleep disorders in India. Furthermore, as per the All India Institute of Medical Sciences (AIIMS), sleep disorders currently affect 5%-10% of the overall population in India, with their incidence increasing as people age.
The global market is fragmented, with the presence of a large number of local as well as international players. Expansion of product portfolio and mergers & acquisitions are key strategies adopted by vendors.
SOMNOmedics GmbH, Natus Medical Incorporated, Allengers, Cadwell Industries Inc., Neurosoft, Hiwin Corporation, Medicom MTD Ltd., Compumedics Limited, Cleveland Medical Devices Inc., NOVOS Labs, Guangzhou Weili Medical Equipment Co., Ltd., Nomics S.A., and Nox Medical are key entities operating in this industry.
Each of these players has been profiled in the polysomnography devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
Attribute |
Detail |
Market Size Value in 2021 |
US$ 253.9 Mn |
Market Forecast Value in 2031 |
More than US$ 419.5 Mn |
Growth Rate (CAGR) |
4.6% |
Forecast Period |
2022–2031 |
Historical Data Available for |
2017–2020 |
Quantitative Units |
US$ Mn for Value |
Market Analysis |
It includes segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
It was valued at US$ 253.9 Mn in 2021
It is projected to reach more than US$ 419.5 Mn by 2031
The CAGR is anticipated to be 4.6% from 2022 to 2031
Increase in prevalence of sleep disorders and availability of portable and home-based devices
North America is expected to account for the largest share from 2022 to 2031
SOMNOmedics GmbH, Natus Medical Incorporated, Allengers, Cadwell Industries Inc., Neurosoft, Hiwin Corporation, Medicom MTD Ltd., Compumedics Limited, Cleveland Medical Devices Inc., NOVOS Labs, Guangzhou Weili Medical Equipment Co., Ltd., Nomics S.A., and Nox Medical
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Polysomnography Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Polysomnography Devices Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projection (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/Globally
5.3. Overview of Sleep Disorders
5.4. COVID-19 Pandemic Impact on Industry
6. Global Polysomnography Devices Market Analysis and Forecast, By Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast By Product, 2017-2031
6.3.1. Stationary
6.3.2. Portable
6.4. Market Attractiveness By Product
7. Global Polysomnography Devices Market Analysis and Forecast, By Channel
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast By Channel, 2017-2031
7.3.1. > 10 Channel
7.3.2. > 16 Channel
7.3.3. > 32 Channel
7.3.4. > 56 Channel
7.4. Market Attractiveness By Channel
8. Global Polysomnography Devices Market Analysis and Forecast, By End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast By End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Others
8.4. Market Attractiveness By End-user
9. Global Polysomnography Devices Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Polysomnography Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product, 2017-2031
10.2.1. Stationary
10.2.2. Portable
10.3. Market Value Forecast By Channel, 2017-2031
10.3.1. > 10 Channel
10.3.2. > 16 Channel
10.3.3. > 32 Channel
10.3.4. > 56 Channel
10.4. Market Value Forecast By End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Market Value Forecast By Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Channel
10.6.3. By End-user
10.6.4. By Country
11. Europe Polysomnography Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product, 2017-2031
11.2.1. Stationary
11.2.2. Portable
11.3. Market Value Forecast By Channel, 2017-2031
11.3.1. > 10 Channel
11.3.2. > 16 Channel
11.3.3. > 32 Channel
11.3.4. > 56 Channel
11.4. Market Value Forecast By End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Market Value Forecast By Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Channel
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Polysomnography Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2017-2031
12.2.1. Stationary
12.2.2. Portable
12.3. Market Value Forecast By Channel, 2017-2031
12.3.1. > 10 Channel
12.3.2. > 16 Channel
12.3.3. > 32 Channel
12.3.4. > 56 Channel
12.4. Market Value Forecast By End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Market Value Forecast By Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Channel
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Polysomnography Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product, 2017-2031
13.2.1. Stationary
13.2.2. Portable
13.3. Market Value Forecast By Channel, 2017-2031
13.3.1. > 10 Channel
13.3.2. > 16 Channel
13.3.3. > 32 Channel
13.3.4. > 56 Channel
13.4. Market Value Forecast By End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Market Value Forecast By Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Channel
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Polysomnography Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product, 2017-2031
14.2.1. Stationary
14.2.2. Portable
14.3. Market Value Forecast By Channel, 2017-2031
14.3.1. > 10 Channel
14.3.2. > 16 Channel
14.3.3. > 32 Channel
14.3.4. > 56 Channel
14.4. Market Value Forecast By End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Others
14.5. Market Value Forecast By Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Channel
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
15.2. Market Share/Ranking Analysis By Company (2021)
15.3. Company Profiles
15.3.1. SOMNOmedics GmbH
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Natus Medical Incorporated
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Allengers
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Cadwell Industries Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Neurosoft
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Hiwin Corporation
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Medicom MTD Ltd.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Compumedics Limited
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Cleveland Medical Devices Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. NOVOS Labs
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Guangzhou Weili Medical Equipment Co., Ltd.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Strategic Overview
15.3.12. Nomics S.A.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Strategic Overview
15.3.13. Nox Medical
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Strategic Overview
List of Tables
Table 01: Global Polysomnography Devices Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 02: Global Polysomnography Devices Market Value (US$ Mn) Forecast, by Channel, 2017‒2031
Table 03: Global Polysomnography Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Polysomnography Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Polysomnography Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Polysomnography Devices Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 07: North America Polysomnography Devices Market Value (US$ Mn) Forecast, by Channel, 2017‒2031
Table 08: North America Polysomnography Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Polysomnography Devices Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 10: Europe Polysomnography Devices Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 11: Europe Polysomnography Devices Market Value (US$ Mn) Forecast, by Channel, 2017‒2031
Table 12: Europe Polysomnography Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Polysomnography Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Polysomnography Devices Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 15: Asia Pacific Polysomnography Devices Market Value (US$ Mn) Forecast, by Channel, 2017‒2031
Table 16: Asia Pacific Polysomnography Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Polysomnography Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Polysomnography Devices Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 19: Latin America Polysomnography Devices Market Value (US$ Mn) Forecast, by Channel, 2017‒2031
Table 20: Latin America Polysomnography Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Polysomnography Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Polysomnography Devices Market Value (US$ Mn) Forecast, by Product, 2017‒2031
Table 23: Middle East & Africa Polysomnography Devices Market Value (US$ Mn) Forecast, by Channel, 2017‒2031
Table 24: Middle East & Africa Polysomnography Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Polysomnography Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Polysomnography Devices Market Value Share, by Product, 2021
Figure 03: Global Polysomnography Devices Market Value Share, by Channel, 2021
Figure 04: Global Polysomnography Devices Market Value Share, by End-user, 2021
Figure 05: Global Polysomnography Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 06: Global Polysomnography Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 09: Global Polysomnography Devices Market Value Share Analysis, by Channel, 2021 and 2031
Figure 10: Global Polysomnography Devices Market Attractiveness Analysis, by Channel, 2022–2031
Figure 11: Global Polysomnography Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 12: Global Polysomnography Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 13: Global Polysomnography Devices Market Value Share Analysis, by Region, 2021 and 2031
Figure 14: Global Polysomnography Devices Market Attractiveness Analysis, by Region, 2022–2031
Figure 15: North America Polysomnography Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 16: North America Polysomnography Devices Market Value Share Analysis, by Country, 2021 and 2031
Figure 17: North America Polysomnography Devices Market Attractiveness Analysis, by Country, 2022–2031
Figure 18: North America Polysomnography Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 19: North America Polysomnography Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 20: North America Polysomnography Devices Market Value Share Analysis, by Channel, 2021 and 2031
Figure 21: North America Polysomnography Devices Market Attractiveness Analysis, by Channel, 2022–2031
Figure 22: North America Polysomnography Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 23: North America Polysomnography Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 24: Europe Polysomnography Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 25: Europe Polysomnography Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 26: Europe Polysomnography Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 27: Europe Polysomnography Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 28: Europe Polysomnography Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 29: Europe Polysomnography Devices Market Value Share Analysis, by Channel, 2021 and 2031
Figure 30: Europe Polysomnography Devices Market Attractiveness Analysis, by Channel, 2022–2031
Figure 31: Europe Polysomnography Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 32: Europe Polysomnography Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 33: Asia Pacific Polysomnography Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 34: Asia Pacific Polysomnography Devices Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 35: Asia Pacific Polysomnography Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 36: Asia Pacific Polysomnography Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 37: Asia Pacific Polysomnography Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 38: Asia Pacific Polysomnography Devices Market Value Share Analysis, by Channel, 2021 and 2031
Figure 39: Asia Pacific Polysomnography Devices Market Attractiveness Analysis, by Channel, 2022–2031
Figure 40: Asia Pacific Polysomnography Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 41: Asia Pacific Polysomnography Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 42: Latin America Polysomnography Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 43: Latin America Polysomnography Devices Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
Figure 44: Latin America Polysomnography Devices Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
Figure 45: Latin America Polysomnography Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 46: Latin America Polysomnography Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 47: Latin America Polysomnography Devices Market Value Share Analysis, by Channel, 2021 and 2031
Figure 48: Latin America Polysomnography Devices Market Attractiveness Analysis, by Channel, 2022–2031
Figure 49: Latin America Polysomnography Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 50: Latin America Polysomnography Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 51: Middle East & Africa Polysomnography Devices Market Value (US$ Mn) Forecast, 2017–2031
Figure 52: Middle East & Africa Polysomnography Devices Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031
Figure 53: Middle East & Africa Polysomnography Devices Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031
Figure 54: Middle East & Africa Polysomnography Devices Market Value Share Analysis, by Product, 2021 and 2031
Figure 55: Middle East & Africa Polysomnography Devices Market Attractiveness Analysis, by Product, 2022–2031
Figure 56: Middle East & Africa Polysomnography Devices Market Value Share Analysis, by Channel, 2021 and 2031
Figure 57: Middle East & Africa Polysomnography Devices Market Attractiveness Analysis, by Channel, 2022–2031
Figure 58: Middle East & Africa Polysomnography Devices Market Value Share Analysis, by End-user, 2021 and 2031
Figure 59: Middle East & Africa Polysomnography Devices Market Attractiveness Analysis, by End-user, 2022–2031
Figure 60: Company Share Analysis, 2021